Inventor · disambiguated record
Douglas J. Sheffler
Also filed as: SHEFFLER DOUGLAS · SHEFFLER DOUGLAS J · SHEFFLER DOUGLAS JAMES
14 granted patents·2 pending applications·22 citations·filing 2009–2023
88Inventor score
Files withLINDSLEY CRAIG W5SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST4SALK INST FOR BIOLOGICAL STUDI3SANFORD BURNHAM MED RES INST2SANFORD BURNHAM PREBYS MEDICAL RES INSTITUTE1
Top patents by PatentIndex Score
16 records- 0186US10597367B2Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereofSANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST·Filed 2018·Granted Mar 24, 2020·3 cites·20 claims
- 0285US10774092B2ULK1 inhibitors and methods using sameSALK INST FOR BIOLOGICAL STUDI·Filed 2019·Granted Sep 15, 2020·3 cites·20 claims
- 0383US10266549B2ULK1 inhibitors and methods using sameSALK INST FOR BIOLOGICAL STUDI·Filed 2015·Granted Apr 23, 2019·5 cites·20 claims
- 0482US10689397B2ULK1 inhibitors and methods using sameSALK INST FOR BIOLOGICAL STUDI·Filed 2019·Granted Jun 23, 2020·2 cites·20 claims
- 0581US9969726B2Metabotropic glutamate receptor negative allosteric modulators (NAMS) and uses thereofSANFORD BURNHAM MED RES INST·Filed 2015·Granted May 15, 2018·2 cites·6 claims
- 0679US12465594B2Compositions and methods for the modulation of the corticotropin releasing factor binding protein and the treatment of alcohol use disorderUNIV BROWN·Filed 2023·Granted Nov 11, 2025·0 cites·4 claims
- 0777US8497289B23.1.0 bicyclic GlyT1 inhibitors and methods of making and using sameLINDSLEY CRAIG W·Filed 2009·Granted Jul 30, 2013·3 cites·8 claims
- 0874US2023113588A1Metabotropic glutamate receptor negative allosteric modulators (nams) and uses thereofSANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST·Filed 2022·Application pending·0 cites
- 0971US8211933B23.3.0 bicyclic GlyT1 inhibitors and methods of making and using sameLINDSLEY CRAIG W·Filed 2009·Granted Jul 3, 2012·1 cites·11 claims
- 1070US8431700B2Alkylsulfonyl-2,3-dihydrospiro[indene-1,4′-piperidine] analogs as GlyT1 inhibitors, methods for making same, and use of same in treating psychiatric disordersLINDSLEY CRAIG W·Filed 2010·Granted Apr 30, 2013·1 cites·8 claims
- 1170US8207155B2Sulfonyl-azetidin-3-yl-methylamine amide analogs as GlyTl inhibitors, methods for making same, and use of same in treating psychiatric disordersLINDSLEY CRAIG W·Filed 2010·Granted Jun 26, 2012·1 cites·10 claims
- 1269US8436019B2Sulfonyl-piperidin-4-yl methylamine amide analogs as GlyT1 inhibitors, methods for making same, and use of same in treating psychiatric disordersLINDSLEY CRAIG W·Filed 2010·Granted May 7, 2013·1 cites·16 claims
- 1366US11447453B2Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereofSANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST·Filed 2020·Granted Sep 20, 2022·0 cites·19 claims
- 1460US2025179000A1Metabotropic glutamate receptor positive allosteric modulators (pams) and uses thereofSANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST·Filed 2022·Application pending·0 cites
- 1549US10099993B2Metabotropic glutamate receptor positive allosteric modulators (PAMS) and uses thereofSANFORD BURNHAM MED RES INST·Filed 2015·Granted Oct 16, 2018·0 cites·24 claims
- 1638US10377695B2Metabotropic glutamate receptor positive allosteric modulators (PAMS) and uses thereofSANFORD BURNHAM PREBYS MEDICAL RES INSTITUTE·Filed 2017·Granted Aug 13, 2019·0 cites·16 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →